Bibliografía
1. Ajani JA, Lee J, Sano T, et al. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. DOI:10.1038/nrdp.2017.36
2. Kim Y, Choi I. Endoscopic management of tumor bleeding from inoperable gastric cancer. Clin Endosc. 2015;48(2):121-127. DOI:10.5946/ce.2015.48.2.121
3. Vasas P, Wiggins T, Chaudry A, et al. Emergency presentation of the gastric cancer; prognosis and implications for service planning. World J Emerg Surg. 2012;7(1):31. Doi: 10.1186/1749-7922-7-31.
4. Kim Y, Choi I, Cho SJ, et al. Outcome of endoscopic therapy for cancer bleeding in patients with unrsectable gastric cancer. J Gastroenterol Hepatol. 2013;28(9):1489-95. DOI: 10.1111/jgh.12262.
5. Koh KH, Kim K, Kwon DH, et al. The successful endoscopic hemostasis factors in bleeding from advanced gastric cancer. Gastric Cancer. 2013;16(3):397-403. DOI:10.1007/s10120-012-0200-3
6. Park H, Ahn JY, Jung HY, et al. Can endoscopic bleeding control improve the prognosis of advanced gastric cancer patients? A retrospective case-control study. 2017;51(7):599-606. DOI: 10.1097/mcg.0000000000000717.
7. Beg S, Al-Bakir I, Bhuva M, et al. Early clinical experience of the safety and efficacy of endoclot in the management of non-variceal upper gastrointestinal bleeding. Endosc Int Open. 2015;3(6):E605-E609. DOI:10.1055/s-0034-1393087.
8. Song IJ, Kim HJ, Lee JA, et al. Clinical outcomes of endoscopic hemostasis for bleeding in patients with unresectable advanced gastric cancer. J Gastric Cancer. 2017;17(4):374-383. DOI:10.5230/jgc.2017.17.e42
9. Maluf-Filho M, Martins BC, de Lima MS, et al. Etiology, endoscopic management and mortality of upper gastrointestinal bleeding in patients with cancer. United European Gastroenterol J. 2013;1(1):60-7. Doi: https://doi.org/10.1177/2050640612474652.
10. Borchard FJ. Classification of gastric carcinoma. Hepatogastroenterology. 1990;37(2):223-232.
11. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49. Doi: 10.1111/apm.1965.64.1.31.
12. Sheibani S, Kim JJ, Chen B, et al. Natural history of acute upper gi bleeding to tumours: short-term success and long-term recurrence with or without endoscopic therapy. Aliment Pharmacol Ther. 2013;38(2):144-50. Doi: https://doi.org/10.1111/apt.12347.
13. Kim YI, Choi IJ, Lee JY, et al. Comparison of the performance of risk scoring systems for tumor bleeding in patients with inoperable gastric cancer. Endoscopy. 2020;52:359-367. Doi: https://doi.org/10.1055/a-1114-6000.
14. Karna R, Deliwala S, Ramgopal B, et al. Efficacy of topical hemostatic agents in malignancy-related GI bleeding: a systematic review and meta-analysis. Gastrointest Endosc. 2023;97(2):202-208. Doi: https://doi.org/10.1016/j.gie.2022.07.033.
15. Saltzman JR, Tabak YP, Hyett BH, et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper gi bleeding. Gastrointest Endosc. 2011;74(6):1215-24. Doi: https://doi.org/10.1016/j.gie.2011.06.024.
16. Stanley AJ, Laine L. Management of upper gastrointestinal bleeding. BMJ. 2019;25:364:l536. Doi: https://doi.org/10.1136/bmj.l536.
17. Wang HM, Huang CM, Zheng CH, et al. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach. World J Gastroenterol. 2012;18(38):5470-5475. Doi: https://doi.org/10.3748/wjg.v18.i38.5470.
18. Bamboat ZM, Tang LH, Vinuela E, et al. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol. 2014;21(5):1678-85. Doi: https://doi.org/10.1245/s10434-013-3466-8.
19. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784-9. Doi: https://doi.org/10.1056/nejmoa001999.
20. Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric cancer, version 2.2022, nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(2):167-192. Doi: https://doi.org/10.6004/jnccn.2022.0008.
21. Hu CG, Hu BE, Zhu ZM, et al. Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients. World J Gastrointest Surg. 2022;14(6):580-593. Doi: https://doi.org/10.4240/wjgs.v14.i6.580.
22. Fang N, Zhang HQ, He B, et al. Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites. Tumour Biol. 2014;35(4):3261-8. Doi: https://doi.org/10.1007/s13277-013-1426-3.
23. Kim YI, Kim MJ, Park SR, et al. Effect of a proton pump inhibitor on tumor bleeding prevention in unresectable gastric cancer patients: a double-blind, randomized, placebo-controlled trial. J Gastric Cancer. 2017;17(2):120-131. Doi: https://doi.org/10.5230/jgc.2017.17.e15.